Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Oct 15, 2007	25-NSE	25-NSE	View HTML 0001143313-07-000175.pdf 0001143313-07-000175.rtf 0001143313-07-000175.xls
Jul 16, 2012	25-NSE	25-NSE	View HTML 0001143313-12-000076.pdf 0001143313-12-000076.rtf 0001143313-12-000076.xls
Jun 11, 2003	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0000891092-03-001290.pdf 0000891092-03-001290.rtf
May 26, 2000	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0000950134-00-005068.pdf 0000950134-00-005068.rtf
Jun 8, 2005	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0001157523-05-005359.pdf 0001157523-05-005359.rtf
Jan 26, 2006	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0001157523-06-000726.pdf 0001157523-06-000726.rtf
Jul 18, 2006	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0001157523-06-006957.pdf 0001157523-06-006957.rtf
Apr 19, 2007	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0001157523-07-003821.pdf 0001157523-07-003821.rtf
Aug 24, 2012	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0001445305-12-002710.pdf 0001445305-12-002710.rtf 0001445305-12-002710.xls
Aug 20, 2013	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	View HTML 0000320017-13-000079.pdf 0000320017-13-000079.rtf 0000320017-13-000079.xls